Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994980 · ClinicalTrials.gov registry record · NA
Duration of Antibiotic Treatment for Early VAP (DATE) Trial
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01994980 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 21 participants.
The verdict
NCT01994980, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Hypothesis: 4 days of antibiotic therapy, as compared to 8 days, is equally effective and results in decreased antibiotic exposure among surgical ICU patients with early VAP.
Interventions
- DRUG Default 4 days antibiotic therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-12 |
| Est. Completion | 2021-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01994980
The ClinicalTrials.gov registry entry for NCT01994980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Default 4 days antibiotic therapy is the first listed.
NCT01994980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01994980 about?
NCT01994980 is a clinical study titled "Duration of Antibiotic Treatment for Early VAP (DATE) Trial". Hypothesis: 4 days of antibiotic therapy, as compared to 8 days, is equally effective and results in decreased antibiotic exposure among surgical ICU patients with early VAP.
What is the current status of trial NCT01994980?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-12. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT01994980?
The interventions under investigation include: Default 4 days antibiotic therapy (DRUG).
Who is sponsoring clinical trial NCT01994980?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.